Dysregulation of cholesterol metabolism is associated with various diseases including chronic kidney disease, atherosclerosis, and Alzheimer's disease. Currently, however, there is no medication that can directly target cholesterol and modulate its metabolism, leaving great medical unmet need.

Renatus focuses on developing effective and safe cholesterol modulators